
Opinion|Videos|August 23, 2024
Comparing Biologics and Biosimilars
Author(s)Sophia Humphreys, PharmD, MHA
Sophia Humphreys, PharmD, MHA, BCBBS, discusses the key differences between biologics and biosimilars.
Advertisement
Episodes in this series

Now Playing
Video content above is prompted by the following:
- What are key differences between biologics and biosimilars in terms of safety, efficacy, and FDA approval, and what sets biosimilars apart from one another?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Clinical Manifestations and Prognostic Impact of Anemia in Myelofibrosis
2
Trump Announces Pricing Deals With 9 Drugmakers, Expanding Most-Favored-Nation Drug Pricing Strategy
3
Pharmacists’ Expanding Role in Optimizing Oral Endocrine and Targeted Breast Cancer Therapies
4
FDA Approves Nerandomilast for Progressive Pulmonary Fibrosis
5
































































































































































































